Second-Look Colonoscopies and the Impact on Capacity in FIT-Based Colorectal Cancer Screening

Esmee Grobbee, A (Atija) Kapidzic, Hanneke van Vuuren, M Leerdam, Iris Lansdorp - Vogelaar, Caspar Looman, Marco Bruno, Ernst Kuipers, Manon Spaander

Research output: Contribution to journalArticleAcademicpeer-review

6 Citations (Scopus)

Abstract

OBJECTIVES: Fecal immunochemical testing (FIT) and colonoscopy are tandem procedures in colorectal cancer (CRC) screening. A positive FIT predicts advanced neoplasia (AN) that requires endoscopic detection and removal. En bloc or piecemeal resection of AN is associated with a significant rate of residual or recurrent neoplasia. Second-look colonoscopies are indicated to assess completeness of removal of AN. These colonoscopies can make a substantial demand on colonoscopy capacity and health-care system. This study is the first to evaluate the demand and risk factors for second-look colonoscopy in FIT CRC screening. METHODS: All colonoscopies after a positive FIT, in subjects aged 50-74 years approached for 3 rounds of FIT screening, were prospectively registered. Second-look colonoscopies were defined as any colonoscopy within 1 year following a colonoscopy after positive FIT. RESULTS: Out of 1,215 FIT-positive screenees undergoing colonoscopy, 105 (8.6%) patients underwent a second-look colonoscopy, of whom 30 (2.5%) underwent more than one colonoscopy (range 2-9), leading to a total of 149 (12.3%) additional colonoscopies. Main reasons for second-look colonoscopies were assessment of complete AN removal (41.9%) and need for additional polypectomy (34.3%). Risk factors were advanced adenomas and poor bowel preparation (P < 0.001). High fecal hemoglobin concentration was the only predictor of a second-look colonoscopy before index colonoscopy (P < 0.001). CONCLUSIONS: Second-look colonoscopies have substantial impact on colonoscopy resources, increasing the demand with 12%. The main reasons for these second-look colonoscopies were previous incomplete polypectomy and control of completeness of removal of neoplastic lesions. A high fecal hemoglobin concentration as measured by FIT can help to identify patients at risk of a second-look colonoscopy.
Original languageUndefined/Unknown
Pages (from-to)1072-1077
Number of pages6
JournalAmerican Journal of Gastroenterology
Volume110
Issue number7
DOIs
Publication statusPublished - 2015

Research programs

  • EMC MM-04-20-01
  • EMC NIHES-02-65-01

Cite this